Cargando…
Bowman-Birk Inhibitors: Insights into Family of Multifunctional Proteins and Peptides with Potential Therapeutical Applications
Bowman-Birk inhibitors (BBIs) are found primarily in seeds of legumes and in cereal grains. These canonical inhibitors share a highly conserved nine-amino acids binding loop motif CTP1SXPPXC (where P1 is the inhibitory active site, while X stands for various amino acids). They are natural controller...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7760496/ https://www.ncbi.nlm.nih.gov/pubmed/33255583 http://dx.doi.org/10.3390/ph13120421 |
_version_ | 1783627346294603776 |
---|---|
author | Gitlin-Domagalska, Agata Maciejewska, Aleksandra Dębowski, Dawid |
author_facet | Gitlin-Domagalska, Agata Maciejewska, Aleksandra Dębowski, Dawid |
author_sort | Gitlin-Domagalska, Agata |
collection | PubMed |
description | Bowman-Birk inhibitors (BBIs) are found primarily in seeds of legumes and in cereal grains. These canonical inhibitors share a highly conserved nine-amino acids binding loop motif CTP1SXPPXC (where P1 is the inhibitory active site, while X stands for various amino acids). They are natural controllers of plants’ endogenous proteases, but they are also inhibitors of exogenous proteases present in microbials and insects. They are considered as plants’ protective agents, as their elevated levels are observed during injury, presence of pathogens, or abiotic stress, i.a. Similar properties are observed for peptides isolated from amphibians’ skin containing 11-amino acids disulfide-bridged loop CWTP1SXPPXPC. They are classified as Bowman-Birk like trypsin inhibitors (BBLTIs). These inhibitors are resistant to proteolysis and not toxic, and they are reported to be beneficial in the treatment of various pathological states. In this review, we summarize up-to-date research results regarding BBIs’ and BBLTIs’ inhibitory activity, immunomodulatory and anti-inflammatory activity, antimicrobial and insecticidal strength, as well as chemopreventive properties. |
format | Online Article Text |
id | pubmed-7760496 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-77604962020-12-26 Bowman-Birk Inhibitors: Insights into Family of Multifunctional Proteins and Peptides with Potential Therapeutical Applications Gitlin-Domagalska, Agata Maciejewska, Aleksandra Dębowski, Dawid Pharmaceuticals (Basel) Review Bowman-Birk inhibitors (BBIs) are found primarily in seeds of legumes and in cereal grains. These canonical inhibitors share a highly conserved nine-amino acids binding loop motif CTP1SXPPXC (where P1 is the inhibitory active site, while X stands for various amino acids). They are natural controllers of plants’ endogenous proteases, but they are also inhibitors of exogenous proteases present in microbials and insects. They are considered as plants’ protective agents, as their elevated levels are observed during injury, presence of pathogens, or abiotic stress, i.a. Similar properties are observed for peptides isolated from amphibians’ skin containing 11-amino acids disulfide-bridged loop CWTP1SXPPXPC. They are classified as Bowman-Birk like trypsin inhibitors (BBLTIs). These inhibitors are resistant to proteolysis and not toxic, and they are reported to be beneficial in the treatment of various pathological states. In this review, we summarize up-to-date research results regarding BBIs’ and BBLTIs’ inhibitory activity, immunomodulatory and anti-inflammatory activity, antimicrobial and insecticidal strength, as well as chemopreventive properties. MDPI 2020-11-25 /pmc/articles/PMC7760496/ /pubmed/33255583 http://dx.doi.org/10.3390/ph13120421 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Gitlin-Domagalska, Agata Maciejewska, Aleksandra Dębowski, Dawid Bowman-Birk Inhibitors: Insights into Family of Multifunctional Proteins and Peptides with Potential Therapeutical Applications |
title | Bowman-Birk Inhibitors: Insights into Family of Multifunctional Proteins and Peptides with Potential Therapeutical Applications |
title_full | Bowman-Birk Inhibitors: Insights into Family of Multifunctional Proteins and Peptides with Potential Therapeutical Applications |
title_fullStr | Bowman-Birk Inhibitors: Insights into Family of Multifunctional Proteins and Peptides with Potential Therapeutical Applications |
title_full_unstemmed | Bowman-Birk Inhibitors: Insights into Family of Multifunctional Proteins and Peptides with Potential Therapeutical Applications |
title_short | Bowman-Birk Inhibitors: Insights into Family of Multifunctional Proteins and Peptides with Potential Therapeutical Applications |
title_sort | bowman-birk inhibitors: insights into family of multifunctional proteins and peptides with potential therapeutical applications |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7760496/ https://www.ncbi.nlm.nih.gov/pubmed/33255583 http://dx.doi.org/10.3390/ph13120421 |
work_keys_str_mv | AT gitlindomagalskaagata bowmanbirkinhibitorsinsightsintofamilyofmultifunctionalproteinsandpeptideswithpotentialtherapeuticalapplications AT maciejewskaaleksandra bowmanbirkinhibitorsinsightsintofamilyofmultifunctionalproteinsandpeptideswithpotentialtherapeuticalapplications AT debowskidawid bowmanbirkinhibitorsinsightsintofamilyofmultifunctionalproteinsandpeptideswithpotentialtherapeuticalapplications |